Latest Breaking News On - Eva kalias - Page 2 : comparemela.com

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China
Austria
France
United-kingdom
Germany
Spain
Pratteln
Switzerland-general
Switzerland
Highbridge
Somerset
United-states

Santhera Pharmaceuticals Holding AG: Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA

Santhera Pharmaceuticals Holding AG: Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China
Pratteln
Switzerland-general
Switzerland
Morningside
North-lanarkshire
United-kingdom
Chinese
Eva-kalias
Dennis-riedl
Breakthrough-therapy-program
Head-investor-relations-communications

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA -March 27, 2024 at 02:01 am EDT

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA -March 27, 2024 at 02:01 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

China
Pratteln
Switzerland-general
Switzerland
United-kingdom
United-states
Morningside
North-lanarkshire
Chinese
Swiss
America
Eva-kalias

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

China
Morningside
North-lanarkshire
United-kingdom
Pratteln
Switzerland-general
Switzerland
United-states
Swiss
America
Chinese
Eva-kalias

Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology

Santhera Announces Publication of Efficacy, Safety and Tolerability Data with Vamorolone (AGAMREE®) in Patients with Duchenne Muscular Dystrophy in Neurology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pratteln
Switzerland-general
Switzerland
United-states
Germany
United-kingdom
America
Swiss
German
Eva-kalias
Drug-administration
Santhera-pharmaceuticals